Benzyl ((S)-2-((tert-butoxycarbonyl)amino)-4-phenylbutanoyl)-D-leucyl-L-phenylalaninate

Catalog No. :
ACGIHS358
CAS No. :
2049024-22-6
Molecular Formula :
C37H47N3O6
Molecular Weight :
629.80

IUPAC Name:benzyl ((S)-2-((tert-butoxycarbonyl)amino)-4-phenylbutanoyl)-D-leucyl-L-phenylalaninate

Benzyl ((S)-2-((tert-butoxycarbonyl)amino)-4-phenylbutanoyl)-D-leucyl-L-phenylalaninate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBenzyl ((S)-2-((tert-butoxycarbonyl)amino)-4-phenylbutanoyl)-D-leucyl-L-phenylalaninate
IUPAC Namebenzyl ((S)-2-((tert-butoxycarbonyl)amino)-4-phenylbutanoyl)-D-leucyl-L-phenylalaninate
Molecular FormulaC37H47N3O6
Molecular Weight629.80
SMILESCC(C)(C)OC(N[C@@H](CCC1=CC=CC=C1)C(N[C@H](CC(C)C)C(N[C@@H](CC2=CC=CC=C2)C(OCC3=CC=CC=C3)=O)=O)=O)=O
InChI KeyAKIABKDAWVWIHO-QAXCHELISA-N
Synonym(6S,9R,12S)-Benzyl 12-benzyl-9-isobutyl-2,2-dimethyl-4,7,10-trioxo-6-phenethyl-3-oxa-5,8,11-triazatridecan-13-oate;(6S,9R,12S)-Benzyl 12-Benzyl-9-isobutyl-2,2-dimethyl-4,7,10-trioxo-6-phenethyl-3-oxa-5,8,11-triazatridecan-13-oate (SM1-B);Kyprolis Impurity N;Carfilzomib Impurity N;Carfilzomib impurities10136-0318
CAS No.2049024-22-6

Synthetic Route by SureRoute

1. ACGIHS358 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGIHS358 route product structure diagram
    ACGIHS3582049024-22-6
Inquiry

2. ACGIHS358 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGIHS358 route product structure diagram
    ACGIHS3582049024-22-6
Inquiry

Comments (0)